![Men aged 12-29 can switch to Pfizer vaccine due to risk of heart inflammation linked to Moderna | NHK WORLD-JAPAN News Men aged 12-29 can switch to Pfizer vaccine due to risk of heart inflammation linked to Moderna | NHK WORLD-JAPAN News](https://www3.nhk.or.jp/nhkworld/en/news/backstories/1813/images/sOk83MBZmcTetRQaJO56kK81yVxzskwQKGefwlZf.png)
Men aged 12-29 can switch to Pfizer vaccine due to risk of heart inflammation linked to Moderna | NHK WORLD-JAPAN News
![Woman died of myocarditis that was likely linked to COVID-19 vaccine booster she received 4 days earlier: Coroner - CNA Woman died of myocarditis that was likely linked to COVID-19 vaccine booster she received 4 days earlier: Coroner - CNA](https://onecms-res.cloudinary.com/image/upload/s--6iCSHpP9--/c_crop,h_450,w_800,x_0,y_82/fl_relative,g_south_east,l_one-cms:core:watermark:reuters,w_0.1/f_auto,q_auto/c_fill,g_auto,h_676,w_1200/v1/one-cms/core/2023-01-25t203440z_4_lynxmpej0o0rm_rtroptp_3_health-coronavirus-vaccine.jpg?itok=EvlusXEa)
Woman died of myocarditis that was likely linked to COVID-19 vaccine booster she received 4 days earlier: Coroner - CNA
![Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-022-07823-3/MediaObjects/12879_2022_7823_Fig2_HTML.png)
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text
![Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ... Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...](https://onlinelibrary.wiley.com/cms/asset/d9db542c-2b63-4a89-b912-de9fd2e75596/ejhf2669-toc-0001-m.jpg)
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...
![Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC) Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC)](https://mvec.mcri.edu.au/wp-content/uploads/2022/03/Myo-recommendations_October-2022-image.jpg)
Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC)
![Vaccines | Free Full-Text | Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients Vaccines | Free Full-Text | Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients](https://pub.mdpi-res.com/vaccines/vaccines-09-01186/article_deploy/html/images/vaccines-09-01186-g004.png?1634560197)
Vaccines | Free Full-Text | Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford
![Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7114e1_Post-infectionMyocarditis_IMAGE_1April22_1200x675_1-medium.jpg?_=68123)
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
![Vaccines | Free Full-Text | A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously Vaccines | Free Full-Text | A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously](https://pub.mdpi-res.com/vaccines/vaccines-11-00541/article_deploy/html/images/vaccines-11-00541-ag.png?1682041650)
Vaccines | Free Full-Text | A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously
![Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7114e1_Post-infectionMyocarditis_IMAGE_1April22_1200x675_1.jpg?_=68123)
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
![Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022 | MMWR Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7107e1-F-large.gif?_=29662)